Patent · US Active

Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines

US10865210B2 · kind B2 · utility

4Cited by

1References

37Claims

0Family size

Assignee

G1 Therapeutics, Inc. · US

Inventors

Alexander Smith · Apex, US
Hannah S. White · Chapel Hill, US
Francis Xavier Tavares · Durham, US
Sergiy Krasutsky · Delmar, US
Jian-Xie Chen · Fryeburg, US
Roberta L. Dorrow · Kalamazoo, US
Hua Zhong · Acton, US

Key dates

Filing date	Dec 21, 2018
Grant date	Dec 15, 2020
Priority date	—
Expiry date	Dec 21, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

This invention is in the area of synthesizing pyrimidine-based compounds useful in the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.